Estimation of intrathecal IgG synthesis: simulation of the risk of underestimation

Annals of Clinical and Translational Neurology
Mickael BonnanBruno Barroso

Abstract

The low level of passively diffused IgG through the blood-brain barrier is sufficient to blur the estimation of intrathecal IgG synthesis (ITS). Therefore, this estimation requires a mathematical calculation derived from empirical laws, but the range of normal values in healthy controls is wide enough to prevent a precise calculation. This study investigated the precision of various methods of ITS estimations and their application to two clinical situations: plasma exchange and immune suppression targeting ITS. Based on a mathematical model of ITS, we constructed a population of healthy controls and applied a tunable ITS. We demonstrate the following results: underestimation of ITS is common at individual level but true ITS is well fitted by cohorts; Q IgG increases after plasma exchange; IgG Loc calculation based on Qlim falsely increases when Q Alb decreases; the sample size required to demonstrate a decrease in ITS increases exponentially with larger Q Alb. Studies evaluating changes in ITS level should be adjusted to Q Alb. Low amounts of ITS could be largely underestimated.

References

Mar 30, 1987·Clinica Chimica Acta; International Journal of Clinical Chemistry·H Reiber, K Felgenhauer
Dec 15, 1974·Klinische Wochenschrift·K Felgenhauer
Jan 1, 1993·Journal of Neurology, Neurosurgery, and Psychiatry·A ZemanE Thompson
Aug 11, 2001·Clinica Chimica Acta; International Journal of Clinical Chemistry·H Reiber
Dec 21, 2002·Journal of Clinical Apheresis·Mark E Brecher
Jul 22, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kevin C O'ConnorKai W Wucherpfennig
Feb 24, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S MatàF Lolli
Jun 4, 2008·European Journal of Immunology·Hans-Christian von BüdingenNorbert Goebels
Nov 16, 2010·Journal of Neural Transmission·Dominik MadžarPiotr Lewczuk
Nov 2, 2011·Multiple Sclerosis : Clinical and Laboratory Research·Felipe von GlehnCarlos Otávio Brandão
Oct 25, 2012·Multiple Sclerosis : Clinical and Laboratory Research·A HarrerJ Kraus
Nov 6, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Cigall KadochJames L Rubenstein
Apr 1, 2014·Neurology·Jeppe Romme ChristensenFinn Sellebjerg
Jun 21, 2014·Multiple Sclerosis : Clinical and Laboratory Research·R MancusoM Clerici
Nov 14, 2014·Multiple Sclerosis : Clinical and Laboratory Research·Clemens WarnkeBernd C Kieseier
Feb 6, 2015·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kristian P DoyleMarion S Buckwalter
Oct 4, 2015·Multiple Sclerosis : Clinical and Laboratory Research·Rikke RatzerFinn Sellebjerg
Oct 28, 2015·Annals of Neurology·Esther Castillo-GomezHannelore Ehrenreich
Nov 21, 2015·Neurology. Neuroimmunology and Neuroinflammation·Johannes PiepgrasKlemens Ruprecht
Jan 26, 2016·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M AuerF Deisenhammer
Jan 6, 2018·Journal of Neuroimmunology·Patrick M Meyer SauteurBart C Jacobs

❮ Previous
Next ❯

Methods Mentioned

BETA
PLEX

Software Mentioned

StatPlus
Q Mean
JMP
ITS
Reibergram
XLSTAT

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.